The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary
- PMID: 35866715
- DOI: 10.2217/nmt-2022-0012
The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary
Abstract
What is this summary about?: This is a plain language summary of an article published in Alzheimer's & Dementia. It looks at a type of test called a lumbar puncture (also known as spinal tap) used in people suspected of having Alzheimer's disease or some other form of dementia. This summary focuses on how to do a lumbar puncture safely.
Why is this important?: Alzheimer's disease is a progressive condition, which means it gets worse over time. This leads to difficulties with thinking and memory. People with Alzheimer's disease show a build up of proteins called amyloid-β and tau in the brain. This is followed by a gradual loss of brain cells and brain function. The changes in the brain are thought to occur years before symptoms appear. Lumbar puncture is a medical procedure during which samples of cerebrospinal fluid are collected. In Alzheimer's disease, it is used to examine cerebrospinal fluid biomarkers that can help diagnose disease. Lumbar puncture is traditionally considered as a painful and invasive procedure with frequent side effects. However, multiple studies indicate that a lumbar puncture can be performed safely. Side effects are typically mild and do not require specialist intervention.
What are the key takeaways?: Despite the low risk of serious complications associated with a lumbar puncture, physicians and their patients may be reluctant to recommend or undergo this procedure. Patient education, specialist training, as well as new methods concerning patient safety are important factors to support the widespread use of lumbar puncture in Alzheimer's disease.
Keywords: Alzheimer's disease; amyloid-β; biomarkers; cerebrospinal fluid; lay summary; lumbar puncture; patient education; plan language summary; specialist training.
Similar articles
-
The AT(N) system for describing biological changes in Alzheimer's disease: a plain language summary.Neurodegener Dis Manag. 2022 Oct;12(5):231-239. doi: 10.2217/nmt-2022-0013. Epub 2022 Jul 22. Neurodegener Dis Manag. 2022. PMID: 35866745
-
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.J Alzheimers Dis. 2014;39(4):719-26. doi: 10.3233/JAD-131334. J Alzheimers Dis. 2014. PMID: 24254700
-
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.J Alzheimers Dis. 2017;55(4):1489-1496. doi: 10.3233/JAD-160827. J Alzheimers Dis. 2017. PMID: 27858714
-
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.Alzheimers Dement. 2018 Nov;14(11):1505-1521. doi: 10.1016/j.jalz.2018.07.220. Epub 2018 Oct 10. Alzheimers Dement. 2018. PMID: 30316776 Free PMC article.
-
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases].Rev Med Interne. 2017 Apr;38(4):250-255. doi: 10.1016/j.revmed.2016.10.383. Epub 2016 Nov 24. Rev Med Interne. 2017. PMID: 27890382 Review. French.
Cited by
-
The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.Alzheimers Dement. 2025 Jan;21(1):e14337. doi: 10.1002/alz.14337. Epub 2024 Dec 23. Alzheimers Dement. 2025. PMID: 39713957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous